GEODE CAPITAL MANAGEMENT, LLC

Position in KRRO — Korro Bio, Inc.

CIK 1214717 BOSTON, MA

Position in KRRO

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$3,912,745

+$1,947,107 QoQ

Shares Held

296,870

+71.0% QoQ

Ownership

2.02%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#17

of 106 holders

Holding Since

Dec 2023

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

GEODE CAPITAL MANAGEMENT, LLC holds $21,877,496,892 across 520 Biotechnology names. KRRO ranks #264 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	6,017,848	$2,989,245,636
2	REGN	Regeneron Pharmaceuticals, Inc.	2,625,810	$1,637,297,566
3	ALNY	Alnylam Pharmaceuticals, Inc.	2,635,840	$793,466,914
4	RVMD	Revolution Medicines, Inc.	3,942,676	$738,384,360
5	MRNA	Moderna, Inc.	9,710,335	$680,014,759
6	INCY	Incyte Corp	4,750,735	$538,543,319
7	RPRX	Royalty Pharma plc	8,058,048	$451,814,751
8	INSM	INSMED Inc	4,220,155	$449,952,925

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$3,912,745	296,870	+71.0%	Shares	Defined	2026-08-12
2026-03-31	$1,965,638	173,643	+6.7%	Shares	Defined	2026-05-15
2025-12-31	$1,303,706	162,760	-0.1%	Shares	Defined	2026-02-09
2025-09-30	$7,802,812	162,932	+4.9%	Shares	Defined	2025-11-12
2025-06-30	$1,940,783	155,387	+10.8%	Shares	Defined	2025-08-08
2025-03-31	$2,441,247	140,221	+2.3%	Shares	Defined	2025-05-13
2024-12-31	$5,218,901	137,087	-0.3%	Shares	Defined	2025-02-12
2024-09-30	$4,595,149	137,497	-1.5%	Shares	Defined	2024-11-12
2024-06-30	$4,730,216	139,658	+139.8%	Shares	Defined	2024-08-09
2024-03-31	$5,241,690	58,241	+1.5%	Shares	Defined	2024-05-13
2023-12-31	$2,749,935	57,374	—	Shares	Defined	2024-02-13
No filing history on record for this holder in this stock.